Hemenway Trust Hemenway Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,183	Closed	-$277K	–	144
2017 Q4	$277K	Sell	2,183 -615	-22%	-$77.3K	0.05%	128
2017 Q3	$329K	Sell	2,798 -150	-5%	-$12.8K	0.07%	99
2017 Q2	$235K	Buy	+2,948	New	+$188K	0.05%	118
2017 Q1	–	Sell	-16,773	Closed	-$628K	–	130
2016 Q4	$628K	Buy	16,773 +3,373	+25%	+$141K	0.16%	75
2016 Q3	$908K	Buy	13,400 +200	+2%	+$14.1K	0.23%	68
2016 Q2	$732K	Buy	13,200 +525	+4%	+$33.1K	0.19%	71
2016 Q1	$796K	Buy	12,675 +150	+1%	+$9.97K	0.21%	67
2015 Q4	$1.18M	Hold	12,525	–	–	0.31%	59
2015 Q3	$1.01M	Buy	12,525 +245	+2%	+$27.2K	0.28%	64
2015 Q2	$1.47M	Buy	12,280 +150	+1%	+$17.9K	0.38%	55
2015 Q1	$1.27M	Buy	12,130 +60	+0.5%	+$6.08K	0.33%	57
2014 Q4	$1.17M	Buy	12,070 +40	+0.3%	+$3.71K	0.35%	58
2014 Q3	$940K	Buy	12,030 +30	+0.3%	+$1.94K	0.29%	61
2014 Q2	$758K	Hold	12,000	–	–	0.23%	68
2014 Q1	$806K	Sell	12,000 -12,000	-50%	-$929K	0.25%	63
2013 Q4	$1.54M	Sell	24,000 -6,000	-20%	-$358K	0.49%	53
2013 Q3	$1.92M	Hold	30,000	–	–	0.72%	46
2013 Q2	$930K	Buy	+30,000	New	+$798K	0.4%	52